C07D 213/80
In position 3
Official title: in position 3
C07D213/80 (In position 3) appears on 1,357 US grants and 853 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,357
- Published applications
- 853
- Assignees
- 627
- Inventors
- 3,432
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 21 | 0 |
| 1977 | 34 | 0 |
| 1978 | 39 | 0 |
| 1979 | 12 | 0 |
| 1980 | 27 | 0 |
| 1981 | 25 | 0 |
| 1982 | 28 | 0 |
| 1983 | 27 | 0 |
| 1984 | 10 | 0 |
| 1985 | 27 | 0 |
| 1986 | 22 | 0 |
| 1987 | 22 | 0 |
| 1988 | 30 | 0 |
| 1989 | 42 | 0 |
| 1990 | 41 | 0 |
| 1991 | 35 | 0 |
| 1992 | 40 | 0 |
| 1993 | 31 | 0 |
| 1994 | 30 | 0 |
| 1995 | 32 | 0 |
| 1996 | 30 | 0 |
| 1997 | 31 | 0 |
| 1998 | 26 | 0 |
| 1999 | 35 | 0 |
| 2000 | 24 | 0 |
| 2001 | 28 | 12 |
| 2002 | 31 | 27 |
| 2003 | 21 | 36 |
| 2004 | 29 | 44 |
| 2005 | 16 | 36 |
| 2006 | 22 | 29 |
| 2007 | 25 | 39 |
| 2008 | 18 | 45 |
| 2009 | 16 | 47 |
| 2010 | 39 | 48 |
| 2011 | 26 | 29 |
| 2012 | 39 | 38 |
| 2013 | 20 | 24 |
| 2014 | 22 | 27 |
| 2015 | 29 | 31 |
| 2016 | 33 | 36 |
| 2017 | 29 | 28 |
| 2018 | 23 | 34 |
| 2019 | 27 | 41 |
| 2020 | 39 | 33 |
| 2021 | 25 | 35 |
| 2022 | 16 | 28 |
| 2023 | 16 | 33 |
| 2024 | 15 | 29 |
| 2025 | 16 | 25 |
| 2026 | 16 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of making nicotinic acid derivatives29 Sep 2026US 12,747,211 B2Syngenta Crop Protection AG
- D-amphetamine compounds, compositions, and processes for making and using the same15 Sep 2026US 12,735,388 B2Zevra Therapeutics, Inc.
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Salts of neuroceuticals and uses thereof25 Aug 2026US 12,714,711 B2SyneuRx International (Taiwan) Corp.
- Nicotinic acid derivative A with anti-inflammation and anti-platelet aggregation activities, and use thereof11 Aug 2026US 12,702,664 B2Chongqing Academy of Chinese Materia Medica
- Herbicidal derivatives1 Oct 2026US 2026/0293895 A1Syngenta Crop Protection AG
- Neuroactive androgen receptor modulators and use thereof1 Oct 2026US 2026/0294908 A1ENDOCHEM PHARMACEUTICALS (BEIJING) CO., LTD. Beijing
- Halogenated benzylidine derivatives and their use in the treatment of cancers10 Sep 2026US 2026/0265180 A1Renovel Innovations, Inc.
- Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethylpyridine-3-carboxylate10 Sep 2026US 2026/0265198 A1Imbria Pharmaceuticals, Inc.
- Pai-1 inhibitors and uses thereof20 Aug 2026US 2026/0242355 A1The Cleveland Clinic Foundation
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity167US 5,919,970 AAllergan Sales, Inc. · 1999
- Acetylenes disubstituted with a pyridinyl group and a substituted phenyl group having retinoid like activity140US 5,013,744 AAllergan, Inc. · 1991
- Process for producing 4-trifluoromethylnicotinic acid129US 5,708,175 AIshihara Sangyo Kaisha, Ltd. · 1998
- Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity125US 5,175,185 AAllergan, Inc. · 1992